MedTrace Logo

High MAP in Septic Shock With Hypertension

NCT01443494 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2017-07-06

Study results available
· View outcomes & findings →

Summary

We hypothesized that the increase in MAP from 65 mmHg to patients' usual level improved sublingual microcirculation.

Conditions

  • Septic Shock

Interventions

OTHER

NE

norepinephine

Sponsors & Collaborators

  • Southeast University, China

    lead OTHER

Principal Investigators

  • Haibo Qiu, MD,PhD · Southeast University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01443494 on ClinicalTrials.gov